(Q37183459)

18 August 2017

1 reference

title

Role of chemotherapy in pediatric nonrhabdomyosarcoma soft-tissue sarcomas (English)

1 reference

18 August 2017

1 reference

Andrea Ferrari

1

0 references

publication date

1 June 2008

1 reference

Expert Review of Anticancer Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

929-938

1 reference

Nonrhabdomyosarcoma in children: prognostic factors influencing survival

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

New concepts for the treatment of pediatric nonrhabdomyosarcoma soft tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue sarcomas: a Pediatric Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: the National Cancer Institute experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Preoperative vs postoperative radiation therapy for extremity soft tissue sarcoma: controversy and present management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Novel therapeutic approaches in pediatric and young adult sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Combined modalities approach for localized adult extremity soft-tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Synovial sarcoma of childhood and adolescence. Report of the German CWS-81 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Synovial sarcoma of childhood and adolescence: a multicenter, multivariate analysis of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Extraosseous localized ewing tumors: improved outcome with anthracyclines--the French society of pediatric oncology and international society of pediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Epithelioid hemangioendothelioma with multiple site involvement. Literature review and observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Imatinib mesylate in chordoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

Hyperthermic Isolated Perfusion With Low-Dose Tumor Necrosis Factor α and Doxorubicin for the Treatment of Limb-Threatening Soft Tissue Sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.6.929

21 January 2018

Identifiers

DOI

10.1586/14737140.8.6.929

1 reference

18 August 2017

1 reference